Call for Abstracts and Sessions at Cannabis Clinical Outcomes Research Conference
The Cannabis Clinical Outcomes Research Conference will take place May 30-31, 2024, in Orlando.
Posts tagged as
Almutwinterstein
Researchers wield AI to address some of pharmacy’s most serious problems
Drs. Almut Winterstein and Jingchuan "Serena" Guo were featured in a Pharmacy Today story about artificial intelligence.
POP’s new home in Malachowsky Hall
Malachowsky Hall for Data Science & Information Technology is the new home for the department of pharmaceutical outcomes and policy.
Dr. Almut Winterstein to participate in webcast addressing the shortcomings in the mycophenolate REMS
Dr. Almut Winterstein will participate as faculty for the "Now More Than Ever: Implementing the Mycophenolate Risk Evaluation and Mitigation Strategy in Clinical Practice" webcast.
ISPE Emerging Leader Award presented to Sebastian Jugl
Jugl is the first graduate student to receive the ISPE Emerging Leader award.
Dr. Almut Winterstein elected to the Academy of Science, Engineering and Medicine of Florida
Fourteen members of the class of 2022 were officially inducted at the ASEMFL Annual Meeting in Orlando on Nov. 5.
UF Health researchers find quinolone ear drops associated with tendon ruptures
Research by Patrick Antonelli, M.D., and Almut Winterstein, Ph.D., shows quinolone ear drops used to treat infection increase the risk of tendon ruptures.
Dr. Winterstein honored with special ISPE award for COVID-19 pandemic contributions
Dr. Winterstein was one of nine ISPE members honored with the award at the 38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management in Copenhagen, Denmark.
From Florida Podcast: What is Florida’s medical marijuana research consortium studying – and what has it found so far?
Almut Winterstein, Ph.D., joined the From Florida podcast with Nicci Brown to discuss medical marijuana research.
UF study finds 1 in 16 women take harmful drugs during pregnancy
The study published in the American Journal of Obstetrics and Gynecology highlights the need for women and their providers to carefully examine medications taken during pregnancy.
